InvestorsHub Logo
Followers 63
Posts 8502
Boards Moderated 0
Alias Born 01/10/2014

Re: None

Sunday, 04/14/2019 10:01:36 AM

Sunday, April 14, 2019 10:01:36 AM

Post# of 5594
HEXO mentioned in this article regarding FDA May 31st meeting.

U.S. FDA Sets First Hearing on CBD in Food and Drinks
HOUSTON, TX / ACCESSWIRE / April 12, 2019 / The U.S. FDA could provide a substantial boost to cannabis stocks in coming weeks.

On May 31, 2019, the government agency will hold its first public hearing on legalizing CBD in food and drinks, to figure out how to regulate such products.

"The goal of the hearing is to obtain additional scientific data and other information related to cannabis and cannabis-derived compounds, both from botanical and synthetic sources, to inform our regulatory oversight of these products," the agency has noted. "FDA does not intend for this hearing to produce any decisions or new positions on specific regulatory questions, but this hearing is expected to be an important step in our continued evaluation of cannabis and cannabis-derived compounds in FDA-regulated products."

Any positive outcome is likely to be a big catalyst for related stocks, including Blissco Cannabis Corp. (CSE: BLIS)(OTCQB: HSTRF), Tilray Inc. (NASDAQ: TLRY), and HEXO Corporation (NYSE: HEXO)(TO: HEXO).


https://finance.yahoo.com/news/u-fda-sets-first-hearing-150000260.html


Statements made are only my opinion. Do your own DD in order to make your Investment decisions.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y